EP0455666A1 - Regulation of plant gene expression - Google Patents
Regulation of plant gene expressionInfo
- Publication number
- EP0455666A1 EP0455666A1 EP90901856A EP90901856A EP0455666A1 EP 0455666 A1 EP0455666 A1 EP 0455666A1 EP 90901856 A EP90901856 A EP 90901856A EP 90901856 A EP90901856 A EP 90901856A EP 0455666 A1 EP0455666 A1 EP 0455666A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gene
- dna
- plant
- operator
- binding protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 43
- 108700001094 Plant Genes Proteins 0.000 title claims abstract description 19
- 230000033228 biological regulation Effects 0.000 title abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 45
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 230000001580 bacterial effect Effects 0.000 claims abstract description 6
- 239000013598 vector Substances 0.000 claims description 19
- 108020004414 DNA Proteins 0.000 claims description 11
- 101710096438 DNA-binding protein Proteins 0.000 claims description 11
- 230000003993 interaction Effects 0.000 claims description 10
- 101150011498 lad gene Proteins 0.000 claims description 9
- 230000009466 transformation Effects 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 4
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 108010034634 Repressor Proteins Proteins 0.000 claims description 4
- 102000009661 Repressor Proteins Human genes 0.000 claims description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 10
- 241000196324 Embryophyta Species 0.000 description 42
- 238000003780 insertion Methods 0.000 description 20
- 230000037431 insertion Effects 0.000 description 20
- 238000000034 method Methods 0.000 description 19
- 239000012634 fragment Substances 0.000 description 15
- 240000008042 Zea mays Species 0.000 description 12
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 12
- 235000009973 maize Nutrition 0.000 description 12
- 238000003752 polymerase chain reaction Methods 0.000 description 11
- 108010054278 Lac Repressors Proteins 0.000 description 9
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 210000001938 protoplast Anatomy 0.000 description 6
- FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 5
- 244000061176 Nicotiana tabacum Species 0.000 description 5
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 108091006104 gene-regulatory proteins Proteins 0.000 description 5
- 102000034356 gene-regulatory proteins Human genes 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 108700026226 TATA Box Proteins 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000008219 male gametogenesis Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 101150078994 La gene Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000701980 Phage 434 Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108700005085 Switch Genes Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000010154 cross-pollination Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229910000078 germane Inorganic materials 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000000754 repressing effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8239—Externally regulated expression systems pathogen inducible
Definitions
- This invention relates to the regulation of plant gene expression. More particularly, the invention is concerned with the regulation of plant gene expression by the use of repressor molecules. The invention also provides materials for use as repressors and methods for the production thereof.
- Traditionally the improvement of crop plant species involves the introduction of desired traits by genetic crosses. However, although these breeding techniques are highly successful, they provide no means of controlling the expression of the newly acquired traits. Recent advances in technology are now allowing the genes responsible for determining plant structure and the productivity and quality of the crop to be identified and isolated. A major aim in the field of improvement is therefore to be able to manipulate complex developmental processes genetically in order to improve crop performance. Essential to this objective is the determination of strategies which allow the expression of specific plant genes to be regulated at will.
- CMS cytoplasmic male sterility
- Control of gene expression in both prokaryotes and eukaryotes relies primarily on the interaction of regulatory proteins with specific DNA sequences. Depending on the nature of these interactions, transcription from the cognate promoters may either be repressed or activated. Indeed, in some cases the same protein may either reduce or enhance transcription according to the nature of the contacts made. Furthermore, the ability of some regulatory proteins to bind their target sequences is modulated by the binding of ligands or by specific proteolytic cleavage. Such mechanisms may be exploited in order to include inducibility amongst strategies for plant gene regulation.
- the best characterised regulatory systems are those of bacteria in which the interactions between the DNA-binding proteins (repressors) and the target DNA sequences (operators) are understood in great detail.
- a comparison of the best understood systems, including repressor and cro proteins of bacteriophage ⁇ and 434, the Lacl repressor and the catabolite gene-activating protein (CAP) reveals several factors in common.
- These regulatory proteins bind as di ers or tetramers to short operators that exhibit a high degree of dyad symmetry. In most cases the domain responsible for DNA-recognition, which is separate from that concerned with oli.gomerisation of the monomers, contains a conserved helix-turn-helix structure.
- a specific helix within this structure in each monomer, the recognition helix, is aligned with the major groove of the DNA and only if specific contacts are formed between the amino acids of this recognition helix and the bases of the adjacent DNA can a functional repressor/operator complex be formed. Such interactions are highly specific, and the high-affinity complexes are formed with extremely rapid kinetics.
- Eukaryotic regulatory systems appear to exhibit a greater diversity of structure and a higher degree of complexity than their prokaryotic counterparts. For instance, control of transcription from eukaryotic promoters is thought to involve the interaction of many proteins (perhaps in the order of tens) with the regulatory DNA. Furthermore, at least three different protein structures (the helix-turn-helix, the zinc-finger and the leucine zipper) have been implicated in the specificity of DNA-binding by various eukaryotic regulatory factors.
- DNA-binding protein constitute a class of proteins characterised by their ability to bind to DNA of genes to give the effect of either repressing or activating the gene to which they bind. Unless the context otherwise requires, such DNA-binding proteins are hereinafter referred to for convenience simply as "repressors" .
- An object of the present invention is to provide means for the control of expression of specific plant genes.
- a recombinant plant gene comprising a repressor gene of bacterial origin and a promoter which operates in plants for driving expression of the repressor gene, said gene encoding a repressor protein capable of interaction with an operator sequence associated with a selected target plant gene so that on expression of the repressor protein expression of the target plant gene is inhibited.
- the invention also provides stably transformed cells containing the said recombinant plant gene.
- the invention further provides a vector, preferably the plasmid, designated p35Slacl, containing the said DNA, which has been deposited in an E.coli, strain TG-2, host with the National Collection of Industrial and Marine Bacteria Limited, Aberdeen, United Kingdom, on 12th December 1988, under the Accession Number NCIB 40092.
- the invention provides a plant transformation vector comprising Agrobacterium tumefaciens, harbouring the plasmid aforesaid.
- a bacterial lad operator system is utilised to regulate gene expression. Lac repression can be relieved by iso-propyl thiogalactoside (IPTG) and other sugar analogues.
- IPTG iso-propyl thiogalactoside
- the method employed for transformation of the plant cells is not especially germane to this invention and any method suitable for the target plant may be employed.
- Transgenic plants are obtained by regeneration from the transformed cells.
- lac repressor lacl ⁇
- the lac repressor (lacl ⁇ ) is available on plasmid pMJR 156.
- the translation initiation codon GTG
- suitable restriction sites Hindlll and Pstl
- a Cfr 10 restriction site is located at position 134.
- pMJR was cut with Cfr 10 and a synthetic DNA fragment which reconstitutes the N-terminus of the lad gene, the altered translational start codon ATG, a plant consensus sequence for efficient translational initiation and a BamHI restriction site were inserted into pJRl.
- the sequence of this synthetic fragment was: BamHI consensus
- the PCR reaction was carried out under the prescribed conditions.
- the product was cut with BamHI (at the newly introduced site) and Pstl.
- the resulting fragment was clones into pJRl cut with BamHI and Pstl. Recombinants were identified by hybridisation and restriction analysis using standard protocols. One of the resulting clones was characterised by DNA sequence analysis.
- this vector was achieved by replacing the CaMV promoter in p35SlacI with the maize CAB promoter, the DNA sequence of which is given in Figure 3 herewith, which is found in vector pCAB48.1.
- the CaMV promoter was removed by restriction of p35SlacI with EcoRI and BamHI using standard conditions.
- the CAB promoter was isolated from pCAB48.1 by restriction with Xbal and Sau3A using partial restriction conditions for Sau3A. This promoter fragment was then inserted into the promoter-less p35SlacI.
- This vector, designated pCABlacI has been characterised by restriction mapping and DNA sequence analysis.
- the expression modules from the vectors described above were transferred to BIN19 and then to tobacco using leaf disc transformation following standard protocols.
- the plasmids were transferred to Agrobacterium using triparental mating.
- Agrobacteria were purified, and used in leaf disc transformation experiments. Thirty-seven plants containing the CaMV-lad expression module and thirty-eight plants containing the BAB-lacl construct were regenerated and analysed for the relative expression of lad. 1.4 Analysis of transgenic plants for lad expression
- the expression of the lad gene was monitored using Western analysis of extracted proteins. Extracts were prepared, proteins recovered on polyacrylamide gels and prepared for Western analysis. The analyses confirmed the expression of the lad gene construct in the transformed plants. Different levels of la gene expression were observed in different independent transformants. The results for plants transformed with the CaMV-lad construct are given in the following Table
- the maize CAB promoter can be found in plasmid pCAB48.1 and we have found that this promoter can drive expression of foreign genes in a transient tobacco expression system and in stably transformed plants. This gene, therefore, is an excellent target to demonstrate control through lad as high levels of expression can be obtained both i_n vitro and iji vivo.
- the CAB promoter from other systems have been extensively analysed in detail and reported in the literature. The published information facilitates the selection of suitable sites for operator insertion.
- pCAB48.1 is a maize promoter and the use of this system is important to demonstrate the applicability of this invention to monocotyledonous plants such as maize, heat, barley and sorghum.
- the restriction enzyme PvuII recognises a single site within the 2.8 kb Pstl fragment containing the CAB gene.
- the site lies between the TATA element and the transcription start point (TSP) of the CAB promoter.
- TTP transcription start point
- the vector pCAB48.1 contains numerous PvuII sites (within pUCl9). Therefore, the 2.8 kb Pstl fragment was cloned into the standard cloning vector pATl53 (which lacks a PvuII site) to give pCABPl.
- pUCl ⁇ was digested with Hindlll and BamHI and the promoter fragment from (i) above was inserted to give pCABP2. Digestion of pUC18 with BamHI removes the single Sphl site from the polylinker. Therefore, pCABP2 contains a unique Sphl site into which operators can be inserted.
- the second oligonucleotide overlaps the Ncol site and contains the operator sequence shown below.
- a slightly different approach which eliminates the intermediate cloning step into pCABPl may also be used. This involves using an oligonucleotide which overlaps the unique Xbal site in the CAB promoter together with the operator nucleotides outlined previously. Digestion of PCR DNA with Xbal/Ncol results in a fragment which can be directly cloned into pCGl and pCG2. However the Xbal to Ncol fragment from the PCR reaction is much larger than the PvuII to Ncol fragment obtained from the previous strategy. Operator insertion between the CAAT and TATA This is effected using PCR.
- a promoter-less 35S vector is an excellent receptor for the insertion of activating sequences.
- the lac operator can be inserted into this vector, p- ⁇ -35S, and once inserted the 35S enhancer is cloned 5' upstream of the lac operator.
- (3) Control of gene expression by lac repressor (a) Control of target gene expression in a transient expression system Plants which express lad constitutively transformed with p351acl may be prepared from protoplasts and, using methods described above) they may be tested for expression of the lad protein. The target gene constructs may then be introduced into the protoplasts using standard methods and protocols. Protoplasts from untransformed plants can serve as control. Further control may be provided by protoplasts from plants expressing the GUS marker gene under the control of the CAB promoter without the operator insertions.
- IPTG can be used to overcome repression by the lac repressor.
- a switchable gene system there is formed a switchable gene system.
- Lac repressor/operator interactions can down-regulate marker gene expression in plants to different levels. This is an important effect in that there may be situations where a different degree of down-regulation may be required.
- suitable operator insertion constructs may be transferred to tobacco plants by the methods described above.
- the regenerated plants may be crossed with the lad expressing plants described above, which express the lac repressor under control of the constitutive CaMV35S promoter.
- Plants may also be constructed which express the lad gene under control of the light-inducible maize CAB promoter. The expression of the lad gene in these plants will then be light-inducible. These plants may be crossed with plants which contain the GUS marker gene from the CaMV promoter containing the lad operator insertion. Insertion of multiple operators into the CAB promoter
- multiple operators can be inserted into the target promoter. This can either be by the insertion of multiple copies of the operator at one site, or the combination of fragments of the promoter in which the operator is inserted at different positions in the promoter, this yielding vectors in which the multiple operators are located at multiple locations in the promoter.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Un gène végétal de recombinaison permettant la régulation de l'expression de gènes, comporte un gène de protéine de répression d'origine bactérienne associé à un opérateur reconnu par la protéine de répression bactérienne, et régulant l'expression d'un gène structurel étranger.A recombinant plant gene allowing the regulation of the expression of genes comprises a repression protein gene of bacterial origin associated with an operator recognized by the bacterial repression protein, and regulating the expression of a foreign structural gene.
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898901674A GB8901674D0 (en) | 1989-01-26 | 1989-01-26 | Regulation of plant gene expression |
GB8901674 | 1989-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0455666A1 true EP0455666A1 (en) | 1991-11-13 |
Family
ID=10650614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP90901856A Withdrawn EP0455666A1 (en) | 1989-01-26 | 1990-01-25 | Regulation of plant gene expression |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0455666A1 (en) |
AU (1) | AU644783B2 (en) |
CA (1) | CA2008696A1 (en) |
GB (1) | GB8901674D0 (en) |
WO (1) | WO1990008829A1 (en) |
ZA (1) | ZA90607B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005560B1 (en) | 1989-10-27 | 2006-02-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US5202422A (en) * | 1989-10-27 | 1993-04-13 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
DE4100594A1 (en) * | 1991-01-08 | 1992-07-09 | Inst Genbiologische Forschung | NEW PLASMIDES FOR THE TIME AND LOCAL CONTROLLED EXPRESSION OF A HETEROLOGICAL PRODUCT IN PLANTS |
CA2316036A1 (en) * | 1999-08-27 | 2001-02-27 | Keqiang Wu | Repressing gene expression in plants |
US7517975B2 (en) | 2000-09-26 | 2009-04-14 | Pioneer Hi-Bred International, Inc. | Nucleotide sequences mediating male fertility and method of using same |
PL1696721T3 (en) | 2003-12-16 | 2010-07-30 | Pioneer Hi Bred Int | Dominant gene suppression transgenes and methods of using same |
EA201070229A1 (en) | 2007-08-03 | 2010-08-30 | Пайонир Хай - Бред Интернэшнл, Инк. | MSCA1 NUCLEOTIC SEQUENCE, AFFECTING MALE PLANT FERTILITY, AND METHOD OF THEIR APPLICATION |
CN104080914A (en) | 2011-06-21 | 2014-10-01 | 先锋国际良种公司 | Methods and compositions for producing male sterile plants |
WO2019043082A1 (en) | 2017-08-29 | 2019-03-07 | Kws Saat Se | Improved blue aleurone and other segregation systems |
-
1989
- 1989-01-26 GB GB898901674A patent/GB8901674D0/en active Pending
-
1990
- 1990-01-25 WO PCT/GB1990/000102 patent/WO1990008829A1/en not_active Application Discontinuation
- 1990-01-25 AU AU49453/90A patent/AU644783B2/en not_active Ceased
- 1990-01-25 EP EP90901856A patent/EP0455666A1/en not_active Withdrawn
- 1990-01-26 ZA ZA90607A patent/ZA90607B/en unknown
- 1990-01-26 CA CA002008696A patent/CA2008696A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO9008829A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU4945390A (en) | 1990-08-24 |
ZA90607B (en) | 1990-10-31 |
GB8901674D0 (en) | 1989-03-15 |
WO1990008829A1 (en) | 1990-08-09 |
AU644783B2 (en) | 1993-12-23 |
CA2008696A1 (en) | 1990-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Huang et al. | DNA binding properties of two Arabidopsis MADS domain proteins: binding consensus and dimer formation. | |
US7151201B2 (en) | Methods and compositions to modulate expression in plants | |
US5567862A (en) | Synthetic insecticidal crystal protein gene | |
EP1177277B1 (en) | Compositions and methods for the modification of gene transcription | |
US5567600A (en) | Synthetic insecticidal crystal protein gene | |
US6329567B1 (en) | Methods for improving seeds | |
CA2359231A1 (en) | Methods and means for modification of plant characteristics using the vernalization gene vrn2 | |
US20050144667A1 (en) | Plant polypeptides and polynucleotides encoding same | |
NZ230375A (en) | Synthetic gene encoding b. thuringiensis insecticidal protein | |
WO1990008830A1 (en) | Hybrid seed production | |
EP0521915A1 (en) | Plant promoter | |
US20100261874A1 (en) | Synthetic genes for plant gums and other hydroxyproline rich glycoproteins | |
AU644783B2 (en) | Regulation of plant gene expression | |
IE920047A1 (en) | Plasmids for controlling expression in plants | |
AU6248298A (en) | Two component plant cell lethality methods and compositions | |
US20030166205A1 (en) | Plant regulatory sequences | |
Gupta et al. | Characterisation and promoter analysis of the Arabidopsis gene encoding high-mobility-group protein HMG-I/Y | |
US6570062B1 (en) | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins | |
AU1968099A (en) | Constitutive plant promoters | |
US5362864A (en) | Trans-activating factor-1 | |
EP0494215A1 (en) | Light-activatable plant promoter | |
AU776152B2 (en) | Plants having modified reproductive capacity | |
EP0583258B1 (en) | Bifunctional genetic markers | |
EP0330479A2 (en) | Plant universal stress-inducible regulatory element | |
JPH03228684A (en) | Improvements related to organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19910711 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ZENECA LIMITED |
|
17Q | First examination report despatched |
Effective date: 19940301 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19940712 |